Kyverna Therapeutics, Inc. (KYTX)
(Delayed Data from NSDQ)
$7.25 USD
-0.60 (-7.64%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $7.24 -0.01 (-0.14%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.70 |
EPS Last Quarter | -1.12 |
Last EPS Surprise | -27.27% |
ABR | 1.40 |
Earnings ESP
|
5.71% |
---|---|
Current Year | -3.35 |
Next Year | -4.08 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.75M | 3.75M | 15.00M | 20.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 3.75M | 3.75M | 15.00M | 20.00M |
Low Estimate | 3.75M | 3.75M | 15.00M | 20.00M |
Year ago Sales | NA | NA | 7.03M | 15.00M |
Year over Year Growth Est. | NA | NA | 113.52% | 33.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.70 | -0.79 | -3.35 | -4.08 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.53 | -0.55 | -3.51 | -2.61 |
High Estimate | -0.53 | -0.55 | -2.56 | -2.61 |
Low Estimate | -0.79 | -0.96 | -3.95 | -4.88 |
Year ago EPS | NA | NA | -89.61 | -3.35 |
Year over Year Growth Est. | NA | NA | 96.26% | -21.79% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.70 | -0.79 | -3.35 | -4.08 |
7 Days Ago | -0.70 | -0.79 | -3.34 | -3.83 |
30 Days Ago | -0.70 | -0.79 | -3.34 | -3.83 |
60 Days Ago | -0.75 | -0.86 | -3.60 | -4.24 |
90 Days Ago | -0.71 | -0.80 | -3.26 | -4.07 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.66 | -0.76 | -3.26 | -3.75 |
Zacks Consensus Estimate | -0.70 | -0.79 | -3.35 | -4.08 |
Earnings ESP | 5.71% | 4.13% | 2.91% | 8.27% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.12 | NA | NA | NA | NA |
Estimate | -0.88 | NA | NA | NA | NA |
Difference | -0.24 | NA | NA | NA | -0.24 |
Surprise | -27.27% | NA | NA | NA | -27.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more